Patents by Inventor María Pilar Sáenz Jiménez

María Pilar Sáenz Jiménez has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • In vitro method to detect bladder transitional cell carcinoma
    Patent number: 8124331
    Abstract: The present invention refers to an in vitro method to detect a bladder transitional cell carcinoma, in an individual, to determine the stage or severity of this cancer in an individual or to monitor the effect of therapy administered to an individual with this cancer; to screen for, identify, develop and evaluate the efficacy of therapeutic compounds against this cancer in order to develop new medicinal products, and also agents that inhibit the expression and/or activity of the FGFR3 protein and/or the effects of this expression.
    Type: Grant
    Filed: March 25, 2004
    Date of Patent: February 28, 2012
    Assignee: Progenika Biopharma, S.A.
    Inventors: Antonio Martínez Martínez, Laureano Simón Buela, Simon Santa Cruz, María Pilar Sáenz Jiménez, Corina Junquera Sánchez-Vallejo, José Javier Gómez Román, Jorge Cuevas González, Miguel Molina Vila
  • IN VITRO METHODS FOR DETECTING RENAL CANCER
    Publication number: 20110098191
    Abstract: The present invention refers to an in vitro method for detecting the presence of renal cancer in an individual, for determining the stage, malignancy or severity of said carcinoma in the individual or for monitoring the effect of the therapy administered to an individual having said cancer; to the search, identification, development and assessment of the efficacy of compounds for therapy for said cancer in an attempt to develop new drugs; as well as to agents inducing Plexin-131 protein expression and/or activity, or to agents inhibiting the effects of Plexin-B1 protein expression and/or activity repression.
    Type: Application
    Filed: September 7, 2010
    Publication date: April 28, 2011
    Applicant: PROGENIKA BIOPHARMA, S.A.
    Inventors: Jose Javier Gomez Roman, Maria Pilar Saenz Jimenez, Jorge Ochoa Garay, Jokin Del Amo Iribarren, Cristina Sanz Ibayondo, Corina Junquera Sanchez-Vallejo, Laureano Simon Buela, Antonio Martinez Martinez, Jose Fernando Val Bernal, Jorge Cuevas Gonzalez
  • IN VITRO METHODS FOR DETECTING RENAL CANCER
    Publication number: 20080274968
    Abstract: The present invention refers to an in vitro method for detecting the presence of renal cancer in an individual, for determining the stage, malignancy or severity of said carcinoma in the individual or for monitoring the effect of the therapy administered to an individual having said cancer; to the search, identification, development and assessment of the efficacy of compounds for therapy for said cancer in an attempt to develop new drugs; as well as to agents inducing Plexin-131 protein expression and/or activity, or to agents inhibiting the effects of Plexin-B1 protein expression and/or activity repression.
    Type: Application
    Filed: April 16, 2008
    Publication date: November 6, 2008
    Applicant: PROGENIKA BIOPHARMA, S.A.
    Inventors: Jose Javier Gomez Roman, Maria Pilar Saenz Jimenez, Jorge Ochoa Garay, Jokin Del Amo Iribarren, Cristina Sanz Ibayondo, Corina Junquera Sanchez-Vallejo, Laureano Simon Buela, Antonio Martinez Martinez, Jose Fernando Val Bernal, Jorge Cuevas Gonzalez
  • In Vitro Methods for Detecting Renal Cancer
    Publication number: 20080015143
    Abstract: The present invention refers to an in vitro method for detecting the presence of renal cancer in an individual, for determining the stage, malignancy or severity of said carcinoma in the individual or for monitoring the effect of the therapy administered to an individual having said cancer; to the search, identification, development and assessment of the efficacy of compounds for therapy for said cancer in an attempt to develop new drugs; as well as to agents inducing Plexin-131 protein expression and/or activity, or to agents inhibiting the effects of Plexin-B1 protein expression and/or activity repression.
    Type: Application
    Filed: June 30, 2004
    Publication date: January 17, 2008
    Inventors: Jose Javier Gomez Roman, Maria Pilar Saenz Jimenez, Jorge Ochoa Garay, Jokin Del Amo Iribarren, Cristina Sanz Ibayondo, Corina Junquera Sanchez-Vallejo, Laureano Simon Buela, Antonio Martinez Martinez, Jose Fernando Val Bernal, Jorge Cuevas-Gonzalez